Dan Mischianu

Carol Davila University of Medicine and Pharmacy

Papers

3

Total Citations

18

H-Index

3

About

Dan Mischianu is a dedicated clinical researcher whose work centers on improving outcomes for men with prostate cancer, with a particular focus on the critical period following radical prostatectomy. His research addresses the full spectrum of post-surgical challenges, from cancer recurrence to quality of life. His most cited work, a 2019 review on therapeutic options for biochemical recurrence after radical prostatectomy (10 citations), provides a vital roadmap for managing patients whose PSA levels rise after surgery, a common and distressing scenario. Mischianu’s contributions are grounded in practical, patient-centered concerns. He has systematically analyzed the complications of radical retropubic prostatectomy (5 citations), offering a candid assessment of surgical risks that helps guide both patient consent and surgical refinement. Furthermore, his work on erectile function recovery (3 citations) tackles one of the most significant long-term side effects of prostate cancer treatment, synthesizing evidence to help men regain quality of life. By bridging the gap between surgical oncology and functional rehabilitation, Mischianu’s research offers a comprehensive view of the prostate cancer journey, making him a valuable voice for clinicians and patients navigating the complexities of survivorship.

Research Focus

Key Achievements

3
H-Index
3
Papers
18
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Therapeutic options in patients with biochemical recurrence after radical prostatectomy (Review)
10 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Carol Davila University of Medicine and Pharmacy

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago